CLINICAL_TRIALS
trial_result
· 2018-03-08
Clinical Trial Update: A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004) [Phase 2]
Summary
A Phase 2 trial investigating MK-8521 for Type 2 Diabetes Mellitus was terminated with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type II Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2018-03-08